Mixed Sleep Apnea | What Happens When Your Brain and Body Both Fail to Breathe?

Sleep apnea is a disorder characterized by repeated interruptions in breathing during sleep. It manifests in three distinct forms. The most common is Obstructive Sleep Apnea (OSA), which occurs when the throat muscles relax and physically block the airway. The second type is Central Sleep Apnea (CSA), a neurological issue where the brain fails to send the proper signals to the muscles that control breathing. Mixed Sleep Apnea is a combination of both. An episode of mixed apnea typically begins with a central event—the brain's failure to initiate a breath—immediately followed by an obstructive event as the individual attempts to resume breathing against a collapsed airway. This dual-component nature makes it a more complex condition to diagnose and manage than either OSA or CSA alone. Understanding this distinction is the first step in recognizing the unique challenges presented by mixed sleep apnea.

The pathophysiology of mixed sleep apnea involves a sequence of neurological and physical failures. The event is initiated by a lack of respiratory effort, consistent with central apnea. This neurological pause means no signal is sent from the brain's respiratory control center to the diaphragm and chest muscles. As the body's oxygen levels begin to drop, the brain is startled into action, triggering a gasp for air. However, the upper airway muscles may remain relaxed and collapsed, leading to a physical obstruction. This transition from a central to an obstructive event defines the mixed apnea episode. The condition is often identified during a sleep study when practitioners observe this specific pattern of initial central pause followed by obstructive struggle.

A definitive diagnosis of mixed sleep apnea requires a comprehensive, in-lab sleep study known as a polysomnogram (PSG). This test monitors various physiological parameters during sleep, including brain waves (EEG), blood oxygen levels, heart rate, breathing effort, and airflow. The PSG allows clinicians to precisely identify both the central and obstructive components of the breathing cessations and determine their frequency. Home sleep apnea tests are generally insufficient for diagnosing mixed apnea because they lack the sophistication to differentiate between the lack of breathing effort (central) and a physical blockage (obstructive).

Untreated mixed sleep apnea poses significant health risks due to chronic oxygen deprivation and fragmented sleep. The repeated stress on the cardiovascular system increases the likelihood of developing hypertension, heart disease, heart attack, and stroke. Furthermore, the constant disruption of the sleep cycle leads to severe daytime fatigue, impaired cognitive function, memory problems, and a diminished quality of life. The condition places a substantial burden on both the brain and the body, making timely and effective treatment essential.

Continuous Positive Airway Pressure (CPAP) is the gold-standard treatment for Obstructive Sleep Apnea. It works by delivering a constant stream of air to keep the airway open. However, in mixed sleep apnea, CPAP only addresses the obstructive part of the problem. It does not correct the underlying neurological issue of central apnea, where the brain fails to signal a breath. In some cases, the constant pressure from a CPAP machine can even worsen central apneas in susceptible individuals, a phenomenon known as complex or treatment-emergent central sleep apnea. Therefore, while it is a starting point, CPAP therapy alone is often insufficient for providing comprehensive treatment for mixed apnea.